Europe approves first-ever Ebola vaccine
European regulators have approved Ebola vaccine Arvebo to protect against the spread of a deadly outbreak in Democratic Republic of Congo.
US pharmaceutical maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.